Request Demo
Last update 18 Jul 2026
HSK41959
Last update 18 Jul 2026
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms HSK41959 |
Target |
Action inhibitors |
Mechanism PRMT5 inhibitors(Protein arginine methyltransferase 5 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HSK41959NCT07699757
Phase Ib Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HSK41959 Tablets in Combination With Standard Therapy in Patients With MTAP Deletion Locally Advanced or Metastatic Solid Tumors
NCT06968572
A Phase I, Open-label, Dose-escalation and Expansion Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of HSK41959 in Patients With MTAP Deletion Locally Advanced or Metastatic Solid Tumors
100 Clinical Results associated with HSK41959
Login to view more data
100 Translational Medicine associated with HSK41959
Login to view more data
100 Patents (Medical) associated with HSK41959
Login to view more data
100 Deals associated with HSK41959
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| metastatic non-small cell lung cancer | Phase 1 | China | 01 Jul 2026 | |
| Methylthioadenosine phosphorylase deletion cancer | Phase 1 | China | 01 Jul 2026 | |
| Pancreatic Ductal Adenocarcinoma | Phase 1 | China | 01 Jul 2026 | |
| Locally Advanced Malignant Solid Neoplasm | Phase 1 | China | 11 Apr 2025 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | 19 | jsyycplnos(labqgclpkk) = dqedzpeotb pichldiyqv (qtgoklrvqf ) View more | Positive | 29 May 2026 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free